Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Protalix BiotherapeuticsScancellExopharmRhinomedAltimmune
SymbolNYSEAMERICAN:PLXLON:SCLPASX:EX1ASX:RNONYSE:ALT
Price Information
Current Price$0.18GBX 6.40A$0.40A$0.26$2.05
52 Week RangeBuyN/AN/AN/ABuy
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/ABuy
Consensus Price Target$3.00N/AN/AN/AN/A
% Upside from Price Target1,554.72% upsideN/AN/AN/AN/A
Trade Information
Market Cap$26.71 million£29.78 million$38.19 million$36.90 million$29.91 million
BetaN/AN/AN/AN/AN/A
Average Volume404,849536,966N/A122,418700,016
Sales & Book Value
Annual RevenueN/AN/A$28,789.00$3.35 millionN/A
Price / SalesN/AN/A1,326.5111.01N/A
CashflowN/AGBX 0.96 per shareA$0.04 per shareA$0.01 per shareN/A
Price / CashN/A6.658.9127.00N/A
Book ValueN/AGBX 2.40 per shareA$0.06 per shareA$0.03 per shareN/A
Price / BookN/AN/A6.258.13N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AGBX (1.50)A($0.04)A($0.05)N/A
Trailing P/E Ratio0.00N/AN/AN/A0.00
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current RatioN/A5.86%16.30%2.03%N/A
Quick RatioN/A5.46%15.91%1.47%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees18419N/AN/AN/A
Shares Outstanding148.38 million465.36 million95.47 million141.93 million15.34 million
Next Earnings Date11/6/2019 (Estimated)N/AN/AN/A11/12/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 Protalix BiotherapeuticsScancellExopharmRhinomedAltimmune

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel